Back to search

Hansa Biopharma Limited

08361712

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

ASHCOMBE COURT, GODALMING, GU7 1LQ
Incorporated 15/01/2013

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Christina Sofie Sjã–Strã–M

director · Since 28/02/2024

GROUP ACCOUNTING MANAGER

SWEDISH · SWEDE · Age 49

Soren Hoffmann

director · Since 05/07/2024

LAWYER

DANISH · DENMARK · Age 59

Persons with Significant Control

Former PSCs

Dr Matthew David Max Crispin

Ceased 19/07/2016

Hansa Biopharma Ab

Ceased 19/07/2016

CompanyRankvs 1467+ SIC 72110 peers
46

Financial strength36th percentile among SIC peers · 9/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 1.96× · 16/20
Longevity13 years trading (max 15) · 13/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
1467Hansa Biopharma Limited
52
How is this score calculated?
Financial strength9/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity13/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

debt financing. However if sufficient financing is not arranged by Hansa Biopharma AB there is a material uncertainty that may cast significant doubt on the company's ability to continue as a going concern. 1.3 Intangible fixed assets other than goodwill Intangible assets relate to patents acquired. Amortisation is recognised so as to write off the cost or valuation of assets less their re

Key FinancialsYear ending 31/12/2024

Net Worth

£10

Balance sheet strength

Cash

£50k

Cash in the bank

Net Current Assets

£282k

Working capital

Current Assets

£577k

Current Liabilities

£294k

Debtors

£527k

Profit After Tax

-£39k

0avg. employees-6

Tax at Year End

Corp tax£16k

Balance Sheet

Intangible assets£2k
Assets less current liabilities£284k
Prepared with CCH Software

EstimatesDerived

YearCurrent Ratio
20241.96
20221.66

Derived from filed accounts. Not audited figures.